The WHO announced to create a global registry to track research into human genetic manipulation., After a call to halt all work on germline genome editing. Moreover, germline genome editing was used in China last year to genetically modify twin baby girls. These technologies hold great promise and hope for those who suffer from diseases we once thought untreatable. But some uses of these technologies also pose unique and unprecedented challenges. Moreover, challenges include ethical, social, regulatory and technical challenges.
A Chinese scientist announced in November that he altered the DNA of twins girls using molecular scissors. And it was to prevent them from contracting HIV. The university fired him and police also investigated him and ordered him to halt his work. Moreover, About 30 nations currently have legislation directly or indirectly barring all clinical use of germline editing.
WHO chief emphasized that countries should not allow any further work on human germline genome editing. Until the technical and ethical implications have been properly considered. Accepting the recommendation of its 18-member expert committee, WHO announced plans for an initial phase of the registry to include both germline and somatic clinical trials